Clinical trials
Observational Lower Urinary Tract Symptoms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 7 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Arbor Research Collaborative for Health | 3 |
| Northwestern University | 3 |
| The Methodist Hospital Research Institute | 3 |
| University of California, Irvine | 2 |
| University of Minnesota | 2 |
| Benaroya Research Institute | 1 |
| ConvaTec Inc. | 1 |
| Hartford HealthCare | 1 |
| Mayo Clinic | 1 |
| Merit Medical Systems, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lower Urinary Tract Symptoms | 26 |
| Prostatic Hyperplasia | 8 |
| Urinary Bladder, Overactive | 7 |
| Fecal Incontinence | 4 |
| Urinary Incontinence | 4 |
| Multiple Sclerosis | 3 |
| Urinary Bladder, Neurogenic | 3 |
| Urinary Incontinence, Urge | 3 |
| Sexual Dysfunction, Physiological | 2 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.